First of all, those 'androgenicity' assays are done in tissue culture, not on humans. Extrapolating from TC to whole organisms is dodgy at the best of times. I put more stock in real world results rather than lab-based assays. It seems to me Bill is making a blanket statement based entirely on an androgenicity/anabolic ratio determioned in a lab, and may have little or no experience with women who have actually compared it to other AAS.
Second, Anavar shows low liver toxicity at doses likely to be used by most women. I would worry more about oral birth control pills that some women take for their whole reproductive life without ever cycling. Winny, at doses taken by pro females, is a little more of a concern for the liver, but again, as long as the cycles are short and infrequent, it's a small risk.
I entirely agree that phenylprop is preferable to decanoate for women, as is any shorter acting ester compared to a longer acting ester. Even better IMHO is unesterified.
Of course many pro females take test. That's a no-brainer. You will also never see a study comparing AAS in healthy young women. Boards like this one are as close as you'll ever get to that kind of study. It will never be placebo controlled, randomized, double-blind cross over LOL, but it's the best we've got for now. From that perspective, pro women are probably the worst females to gauge AAS side effects from. They inevitably mix or stack varying anabolic agents making it impossible to tell which sides are coming from which AAS, or if it's a synergistic effect.
Hvaing said all of that, if nandrolone phenylprop was easily, cheaply and reliably available, I suspect it would be a lot more popular amogst women.
Second, Anavar shows low liver toxicity at doses likely to be used by most women. I would worry more about oral birth control pills that some women take for their whole reproductive life without ever cycling. Winny, at doses taken by pro females, is a little more of a concern for the liver, but again, as long as the cycles are short and infrequent, it's a small risk.
I entirely agree that phenylprop is preferable to decanoate for women, as is any shorter acting ester compared to a longer acting ester. Even better IMHO is unesterified.
Of course many pro females take test. That's a no-brainer. You will also never see a study comparing AAS in healthy young women. Boards like this one are as close as you'll ever get to that kind of study. It will never be placebo controlled, randomized, double-blind cross over LOL, but it's the best we've got for now. From that perspective, pro women are probably the worst females to gauge AAS side effects from. They inevitably mix or stack varying anabolic agents making it impossible to tell which sides are coming from which AAS, or if it's a synergistic effect.
Hvaing said all of that, if nandrolone phenylprop was easily, cheaply and reliably available, I suspect it would be a lot more popular amogst women.